M&A / Deals Bayer banks 3bn in Apollo contraceptives division deal Pharmaceutical TechnologyBayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.Read full story pharminent July 10, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology Bayer’s agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilarNext: GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China Related Stories M&A / Deals Supernus and Indivior merge to create CNS mega-company with 11 approved drugs pharminent August 3, 2026 M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
